Weekly insulin efsitora alfa is non-inferior to daily insulin degludec for reducing HbA1c in type 1 diabetes
1. Once weekly efsitora demonstrated non-inferiority compared with degludec with regards to change in HbA1c. 2. Patients in the efsitora ...
Tag: hypoglycemia
Machine learning model non-invasively detects suspected cases of hypoglycemia during real-world driving
1. Machine learning (ML) models developed by Lehmann and colleagues used driving characteristics and head motion data to detect hypoglycemic ...
Once-weekly insulin icodec non-inferior to daily insulin degludec in patients with type 1 diabetes
1. Mean HbA1c reduction at 26 weeks was comparable in the weekly icodec and daily degludec groups. 2. The risk ...
Orforglipron may be a safe and effective oral GLP-1 agonist for treatment of type 2 diabetes
1. Patients assigned to orforglipron experienced significant reductions in HbA1c, and body weight compared to other groups. 2. The majority ...
Once-weekly insulin icodec non-inferior to daily insulin glargine for patients with type 2 diabetes on basal-bolus regimens
1. At 26 weeks, the mean change in HbA1c was comparable between the weekly insulin icodec and daily glargine U100 ...
Neonatal hypoglycemia not significantly associated with lower educational achievement during childhood
1. In this prospective cohort study neonatal hypoglycemia was not significantly associated with lower educational achievement throughout childhood. 2. Teachers ...
Tirzepatide improves glycemic control and weight loss in patients with type 2 diabetes
1. Tirzepatide was superior to placebo with regard to changes in HbA1c, serum glucose, body weight loss, and proportion of ...
#VisualAbstract: Novel hybrid closed-loop system improves glycemic control in young adults with type 1 diabetes
1. Participants using the novel advanced hybrid insulin delivery system (Medtronic) had a greater proportion of time spent in their ...
![Type I diabetes not associated with early menopause [OVADIA study]](https://www.2minutemedicine.com/wp-content/uploads/2014/12/diabetes1_edited-350x250.jpg)
Novel hybrid closed-loop system improves glycemic control in young adults with type 1 diabetes compared to a commercially available system
1. Participants using the novel advanced hybrid insulin delivery system (Medtronic) had a greater proportion of time spent in their ...
#VisualAbstract: Golimumab effective at preserving insulin production in type 1 diabetes
1. In this randomized, double-blind, phase two trial, the use of golimumab led to more C-peptide production, indicative of improved ...
